Myocet
WSG-AM06 / ADAPT Elderly
Phase 3 small_molecule completed
Quick answer
Myocet for Early Primary Breast Cancer is a Phase 3 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Early Primary Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed